Richter transformation acquiring
PLCG2
mutation during Bruton tyrosine kinase inhibitors treatment
EJHaem
.
2024 Apr 14;5(3):642-645.
doi: 10.1002/jha2.891.
eCollection 2024 Jun.
Authors
Takafumi Tsushima
1
2
,
Nobue Sato
3
,
Yong-Mei Guo
1
,
Hirotaka Nakamura
1
,
Kodai Kunisada
1
,
Song-Gi Chi
1
,
Kenta Akie
4
,
Yuki Takahashi
4
,
Saki Nakamura
4
,
Kaoru Shimada
5
,
Genichiro Ishii
6
,
Yosuke Minami
1
,
Junichiro Yuda
1
Affiliations
1
Department of Hematology and Oncology National Cancer Center Hospital East Kashiwa Japan.
2
Department of Hematology and Oncology Japanese Red Cross Narita Hospital Narita Japan.
3
Pharmaceutical Department National Cancer Center Hospital East Kashiwa Japan.
4
Department of Clinical Laboratories National Cancer Center Hospital East Kashiwa Japan.
5
Department of Radiology National Cancer Center Hospital East Kashiwa Japan.
6
Department of Pathology National Cancer Center Hospital East Kashiwa Japan.
PMID:
38895067
PMCID:
PMC11182410
DOI:
10.1002/jha2.891
No abstract available